Title of article :
Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL
Author/Authors :
Luis and Martيnez-Lorenzo، نويسنده , , Marيa José and Anel، نويسنده , , Alberto and Saez-Gutierrez، نويسنده , , Berta and Royo-Caٌas، نويسنده , , Marيa and Bosque، نويسنده , , Alberto and Alava، نويسنده , , Marيa Angeles and Piٌeiro، نويسنده , , Andrés and Lasierra، نويسنده , , Pilar and Asيn-Ungrيa، نويسنده , , Jaime and Larrad، نويسنده , , Luis، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Pages :
13
From page :
28
To page :
40
Abstract :
The infiltration and accumulation of T cells in the rheumatoid arthritis (RA) synovial fluid (SF) are hallmarks of disease. We aimed to assess the functional relevance of FasL and of APO2L/TRAIL in the persistence of T cells in the rheumatoid SF. We have analyzed the expression of the activation markers HLA-DR and CD69 and also of the death receptor Fas/CD95 and death ligands FasL or APO2L/TRAIL in CD3+ lymphocytes from SF of 62 RA patients, together with their sensitivity to anti-Fas mAb or to rAPO2L/TRAIL, using as controls T lymphocytes present in SF of 20 patients with traumatic arthritis. T lymphocytes infiltrated in SF of RA patients have a chronically activated phenotype, but they are resistant to Fas-induced toxicity. However, they are more susceptible to rAPO2L/TRAIL than T cells in the SF of traumatic arthritis patients. In addition, we found very low amounts of bioactive FasL and APO2L/TRAIL associated with exosomes in SF from RA patients as compared with SF from traumatic arthritis patients. The observation on the sensitivity of RA SF T cells to rAPO2L could have therapeutic implications because bioactive APO2L/TRAIL could be beneficial as a RA treatment.
Keywords :
T lymphocytes , rheumatoid arthritis , TOLERANCE , human , apoptosis
Journal title :
Clinical Immunology
Serial Year :
2007
Journal title :
Clinical Immunology
Record number :
1852040
Link To Document :
بازگشت